CONFRONTING ANTIMICROBIAL RESISTANCE
AMR CONTROL 2015 87
References
1. Institute of Medicine (IOM). Crossing the quality chasm: A new health system for the 21st
century. Washington, DC: National Academy Press; 2001.
2. James JT. A new, evidence-based estimate of patient harms associated with hospital care.
J Patient Saf. 2013 Sep;9(3):122-8.
3. Jha AK, Larizgoitia I, Audera-Lopez C, Prasopa-Plaizier N, Waters H, Bates DW. The global
burden of unsafe medical care: Analytic modelling of observational studies. BMJ Qual Saf.
2013 Oct;22(10):809-15.
4. The Research Priority Setting Working Group of the WHO World Alliance for Patient
Safety, editor. Summary of the evidence on patient safety: Implications for research.
Ashish Jha ed. Geneva: World Health Organization; 2008.
5. Allegranzi B, Bagheri Nejad S, Combescure C, Graafmans W, Attar H, Donaldson L, et al.
Burden of endemic health-care-associated infection in developing countries: Systematic
review and meta-analysis. Lancet. 2011 Jan 15;377(9761):228-41.
6. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, et al. International study of
the prevalence and outcomes of infection in intensive care units. JAMA. 2009 Dec
2;302(21):2323-9.
7. Sievert DM, Ricks P, Edwards JR, Schneider A, Patel J, Srinivasan A, et al. Antimicrobialresistant
pathogens associated with healthcare-associated infections: Summary of data
reported to the national healthcare safety network at the centers for disease control and
prevention, 2009-2010. Infect Control Hosp Epidemiol. 2013 Jan;34(1):1-14.
8. WHO. Antimicrobial resistance: Global report on surveillance. Geneva: World Health
Organization; 2014.
9. Mauldin PD, Salgado CD, Hansen IS, Durup DT, Bosso JA. Attributable hospital cost and
length of stay associated with health care-associated infections caused by antibioticresistant
gram-negative bacteria. Antimicrob Agents Chemother. 2010 Jan;54(1):109-15.
10. Filice GA, Nyman JA, Lexau C, Lees CH, Bockstedt LA, Como-Sabetti K, et al. Excess
costs and utilization associated with methicillin resistance for patients with
staphylococcus aureus infection. Infect Control Hosp Epidemiol. 2010 Apr;31(4):365-73.
11. Roberts RR, Hota B, Ahmad I, Scott RD,2nd, Foster SD, Abbasi F, et al. Hospital and
societal costs of antimicrobial-resistant infections in a chicago teaching hospital:
Implications for antibiotic stewardship. Clin Infect Dis. 2009 Oct 15;49(8):1175-84.
12. Massoud MR, Mensah-Abrampah N, Barker P, Leatherman S, Kelley E, Agins B, et al.
Improving the delivery of safe and effective healthcare in low and middle income
countries. BMJ. 2012 Feb 14;344:e981.
13. Massoud, MR. Askov, A. Reinke, J. Franco, LM. Bornstein, T. Knebel, E. MacAulay, C. A
modern paradigm for improving healthcare quality. 2001. Report No.: USAID, URC.
14. Massoud MR, Mensah-Abrampah N, Sax S, Leatherman S, Agins B, Barker P, et al.
Charting the way forward to better quality health care: How do we get there and what are
the next steps? recommendations from the salzburg global seminar on making health care
better in low- and middle-income economies. Int J Qual Health Care. 2012 Dec;24(6):55863.
15. Batalden PB, Stoltz PK. A framework for the continual improvement of health care:
Building and applying professional and improvement knowledge to test changes in daily
work. Jt Comm J Qual Improv. 1993 Oct;19(10):424,47; discussion 448-52.
16. Langley G, Moen R, Nolan K, Nolan T, Norman C, Provost L. The improvement guide: A
practical approach to enhancing organizational performance. 2nd ed. San Francisco, CA:
Jossey-Bass; 2009.
17. Franco LM, Marquez L. Effectiveness of collaborative improvement: Evidence from 27
applications in 12 less-developed and middle-income countries. BMJ Qual Saf. 2011
Aug;20(8):658-65.
18. Davidoff F. Improvement interventions are social treatments, not pills. Ann Intern Med.
2014 Oct 7;161(7):526-7.
19. OVretveit J, Bate P, Cleary P, Cretin S, Gustafson D, McInnes K, et al. Quality
collaboratives: Lessons from research. Qual Saf Health Care. 2002 Dec;11(4):345-51.
20. Wilson T, Berwick DM, Cleary PD. What do collaborative improvement projects do?
experience from seven countries. Jt Comm J Qual Saf. 2003 Feb;29(2):85-93.
21. Hakkarainen KM, Hedna K, Petzold M, Hagg S. Percentage of patients with preventable
adverse drug reactions and preventability of adverse drug reactions--a meta-analysis.
PLoS One. 2012;7(3):e33236.
22. Gawande AA, Thomas EJ, Zinner MJ, Brennan TA. The incidence and nature of surgical
adverse events in colorado and utah in 1992. Surgery. 1999 Jul;126(1):66-75.
23. Kable AK, Gibberd RW, Spigelman AD. Adverse events in surgical patients in Australia.
Int J Qual Health Care. 2002 Aug;14(4):269-76.
24. Anderson DJ, Podgorny K, Berrios-Torres SI, Bratzler DW, Dellinger EP, Greene L, et al.
Strategies to prevent surgical site infections in acute care hospitals: 2014 update. Infect
Control Hosp Epidemiol. 2014 Jun;35(6):605-27.
25. Coffin SE, Klompas M, Classen D, Arias KM, Podgorny K, Anderson DJ, et al. Strategies
to prevent ventilator-associated pneumonia in acute care hospitals. Infect Control Hosp
Epidemiol. 2008 Oct;29 Suppl 1:S31-40.
26. Lo E, Nicolle L, Classen D, Arias KM, Podgorny K, Anderson DJ, et al. Strategies to
prevent catheter-associated urinary tract infections in acute care hospitals. Infect Control
Hosp Epidemiol. 2008 Oct;29 Suppl 1:S41-50.
27. Marschall J, Mermel LA, Fakih M, Hadaway L, Kallen A, O'Grady NP, et al. Strategies to
prevent central line-associated bloodstream infections in acute care hospitals: 2014
update. Infect Control Hosp Epidemiol. 2014 Jul;35(7):753-71.
28. Mauger B, Marbella A, Pines E, Chopra R, Black ER, Aronson N. Implementing quality
improvement strategies to reduce healthcare-associated infections: A systematic review.
Am J Infect Control. 2014 Oct;42(10 Suppl):S274-83.
29. Hauri AM, Armstrong GL, Hutin YJ. The global burden of disease attributable to
contaminated injections given in health care settings. Int J STD AIDS. 2004 Jan;15(1):7-16.
30. Hutin YJ, Hauri AM, Armstrong GL. Use of injections in healthcare settings worldwide,
2000: Literature review and regional estimates. BMJ. 2003 Nov 8;327(7423):1075.
31. Pepin J, Abou Chakra CN, Pepin E, Nault V, Valiquette L. Evolution of the global burden
of viral infections from unsafe medical injections, 2000-2010. PLoS One. 2014 Jun
9;9(6):e99677.
32. Miller MA, Pisani E. The cost of unsafe injections. Bull World Health Organ.
1999;77(10):808-11.
33. URC. Medical injection safety program - namibia. end of project report (2004-2009).
contract number GHS-I-00-03-00029-00, task order no. 001. Bethesda, Maryland:
University Research Co., LLC for USAID; 2011.
34. URC. USAID health care improvement project: Improving injection safety and waste
management in peri-urban Karachi, Pakistan. contract no. GHN-I-03-07-00003-00.
Bethesda, Maryland: University Research Co., LLC for USAID; 2013.
35. Leape LL, Kabcenell AI, Gandhi TK, Carver P, Nolan TW, Berwick DM. Reducing adverse
drug events: Lessons from a breakthrough series collaborative. Jt Comm J Qual Improv.
2000 Jun;26(6):321-31.
36. Institute for Healthcare Improvement. Changes to prevent healthcare-associated
infections. http://www.ihi.org/resources/pages/changes/changestopreventhais.aspx.;
2014.
37. Morris AC, Hay AW, Swann DG, Everingham K, McCulloch C, McNulty J, et al. Reducing
ventilator-associated pneumonia in intensive care: Impact of implementing a care bundle.
Crit Care Med. 2011 Oct;39(10):2218-24.
38. Klevens RM, Edwards JR, Richards CL,Jr, Horan TC, Gaynes RP, Pollock DA, et al.
Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public
Health Rep. 2007 Mar-Apr;122(2):160-6.